NM_015155.3:c.2164A>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015155.3(LARP4B):c.2164A>G(p.Met722Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000014 in 1,424,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015155.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000933 AC: 2AN: 214330 AF XY: 0.0000171 show subpopulations
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1424948Hom.: 0 Cov.: 31 AF XY: 0.00000282 AC XY: 2AN XY: 708462 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2164A>G (p.M722V) alteration is located in exon 17 (coding exon 17) of the LARP4B gene. This alteration results from a A to G substitution at nucleotide position 2164, causing the methionine (M) at amino acid position 722 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at